BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10600008)

  • 21. Targeting signal and subcellular compartments involved in the intracellular trafficking of HLA-DMB.
    Copier J; Kleijmeer MJ; Ponnambalam S; Oorschot V; Potter P; Trowsdale J; Kelly A
    J Immunol; 1996 Aug; 157(3):1017-27. PubMed ID: 8757605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The MHC class II beta chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal.
    Khalil H; Brunet A; Saba I; Terra R; Sékaly RP; Thibodeau J
    Int Immunol; 2003 Oct; 15(10):1249-63. PubMed ID: 13679394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular and cell surface mapping of HLA DR in the presence and absence of the invariant chain.
    Triantafilou K; Wilson KM; Fernandez N
    Biochem Soc Trans; 1997 May; 25(2):259S. PubMed ID: 9191303
    [No Abstract]   [Full Text] [Related]  

  • 24. HLA-DM stabilizes empty HLA-DR molecules in a chaperone-like fashion.
    vogt AB; Moldenhauer G; Hämmerling GJ; Kropshofer H
    Immunol Lett; 1997 Jun; 57(1-3):209-11. PubMed ID: 9232453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editing of the HLA-DR-peptide repertoire by HLA-DM.
    Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
    EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments.
    Sanderson F; Kleijmeer MJ; Kelly A; Verwoerd D; Tulp A; Neefjes JJ; Geuze HJ; Trowsdale J
    Science; 1994 Dec; 266(5190):1566-9. PubMed ID: 7985027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers.
    Hmama Z; Gabathuler R; Jefferies WA; de Jong G; Reiner NE
    J Immunol; 1998 Nov; 161(9):4882-93. PubMed ID: 9794422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stoichiometry of HLA class II-invariant chain oligomers.
    Koch N; Zacharias M; König A; Temme S; Neumann J; Springer S
    PLoS One; 2011 Feb; 6(2):e17257. PubMed ID: 21364959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MHC class II molecules traffic into lipid rafts during intracellular transport.
    Poloso NJ; Muntasell A; Roche PA
    J Immunol; 2004 Oct; 173(7):4539-46. PubMed ID: 15383586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM.
    Weber DA; Evavold BD; Jensen PE
    Science; 1996 Oct; 274(5287):618-20. PubMed ID: 8849454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
    Ramachandra L; Kovats S; Eastman S; Rudensky AY
    J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Release of DR molecules from complexes with invariant chain through the formation of a C-terminal 25 kDa invariant chain fragment.
    Demotz S; Danieli C
    Mol Immunol; 1993 Dec; 30(18):1623-32. PubMed ID: 8272076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dominant-negative clathrin mutant differentially affects trafficking of molecules with distinct sorting motifs in the class II major histocompatibility complex (MHC) pathway.
    Liu SH; Marks MS; Brodsky FM
    J Cell Biol; 1998 Mar; 140(5):1023-37. PubMed ID: 9490717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of the HLA-DM interaction site on HLA-DR molecules.
    Doebele RC; Busch R; Scott HM; Pashine A; Mellins ED
    Immunity; 2000 Oct; 13(4):517-27. PubMed ID: 11070170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes.
    Peters PJ; Raposo G; Neefjes JJ; Oorschot V; Leijendekker RL; Geuze HJ; Ploegh HL
    J Exp Med; 1995 Aug; 182(2):325-34. PubMed ID: 7629497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mediation by HLA-DM of dissociation of peptides from HLA-DR.
    Sloan VS; Cameron P; Porter G; Gammon M; Amaya M; Mellins E; Zaller DM
    Nature; 1995 Jun; 375(6534):802-6. PubMed ID: 7596415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH.
    Kropshofer H; Arndt SO; Moldenhauer G; Hämmerling GJ; Vogt AB
    Immunity; 1997 Mar; 6(3):293-302. PubMed ID: 9075930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain.
    Sekaly RP; Tonnelle C; Strubin M; Mach B; Long EO
    J Exp Med; 1986 Nov; 164(5):1490-504. PubMed ID: 2430042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of class II expression in monocytic cells after HIV-1 infection.
    Rakoff-Nahoum S; Chen H; Kraus T; George I; Oei E; Tyorkin M; Salik E; Beuria P; Sperber K
    J Immunol; 2001 Aug; 167(4):2331-42. PubMed ID: 11490022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function.
    Busch R; Doebele RC; von Scheven E; Fahrni J; Mellins ED
    J Immunol; 1998 Jan; 160(2):734-43. PubMed ID: 9551909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.